Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.
📚 Books
Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.
Both books are published globally on Amazon (Kindle & Paperback editions available).
🟦 The Mind Game of Trading
Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari
Overview
Trading success is rarely limited by strategy. It is limited by psychology.
In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.
The book focuses on:
• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks
This is not a theory book — it is a practical discipline manual for traders at all levels.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2
🟦 The Stock Market Starter Kit
Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari
Overview
Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.
It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.
It covers:
• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans
Clear. Structured. Actionable.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV
-
BPCL Shares: Maintaining Neutrality Post Strong Q2 Results, Says Motilal Oswal
BPCL Shares: Maintaining Neutrality Post Strong Q2 Results, Says Motilal Oswal Bharat Petroleum Corporation Ltd. (BPCL) has recently announced its Q2 results, which have been well-received by the market. However, according to a report by Motilal Oswal, the brokerage firm remains neutral on the stock, citing the need for clarity on the capex cycle for…
-
Tata Motors Demerger Complete: CV Arm Listing Imminent! Your Ultimate Investor Guide
Tata Motors Demerger: A New Era Begins for India’s Automotive Titan The Indian stock market has been buzzing with anticipation, and the moment has finally arrived. The historic demerger of Tata Motors, a strategic move aimed at unlocking immense value, is now complete. For millions of shareholders, this marks a pivotal moment, transforming their single…
-
Shriram Finance Surges 5%: Brokerages Raise Target Price After Strong Q2 Results – Should You Invest?
Shriram Finance Shares Hit the Fast Lane on Dalal Street Mumbai: It was a stellar Monday for Shriram Finance on the Indian bourses as the stock became a top gainer, surging over 5% in early trade. The share price touched an impressive intraday high of ₹794, a significant jump from its previous close of ₹748.…
-
BEL Share Price Slips Despite Blockbuster Q2 Results: Buy, Sell or Hold This Defence PSU?
BEL’s Paradox: Why a Stellar Report Card Spooked the Street In the often-unpredictable theatre of the Indian stock market, few scenarios are as perplexing as when a company delivers blockbuster financial results, only to see its share price retreat. This was the exact script that played out for Bharat Electronics Ltd. (BEL), a Navratna defence…
-
Lenskart IPO Day 2: Retail Frenzy Ignites 3.33x Subscription! GMP Strong, Should You Invest?
Lenskart IPO Roars on Day 2: Retail Investors Lead the Charge The Indian primary market is buzzing with activity, and the spotlight is firmly on the much-anticipated Initial Public Offering (IPO) of Lenskart Solution Ltd. On the second day of bidding, the omnichannel eyewear giant has witnessed a robust response, particularly from retail investors, signalling…
-
Jubilant Pharmova Q2 Results: EBITDA Shines, But Should You Hold or Fold? A 360° Analysis
Jubilant Pharmova’s Q2 FY24 Report Card: A Tale of Operational Grit The Indian stock market witnessed a nuanced performance from Jubilant Pharmova Ltd. as it unveiled its financial results for the second quarter of fiscal year 2024 (Q2 FY24). For investors tracking the pharma space, the numbers presented a classic case of ‘good in parts’.…